| Literature DB >> 35215336 |
Anna Gajda1, Ewelina Nowacka-Kozak1, Małgorzata Gbylik-Sikorska1, Piotr Cybulski2.
Abstract
The monitoring of antibiotic use in animals is a crucial element to ensure food safety. The main goal of this study was to analyse the distribution of selected antibiotics to porcine oral fluid, as well as to demonstrate that an oral fluid is an alternative to other biological matrices used in the control of antibacterials. Therefore, an animal study with pigs treated using seven different antibiotics was performed. Sulfadoxine (SDX) with trimethoprim (TRMP), lincomycin (LIN), tiamulin (TIAM), tylosin (TYL), amoxicillin (AMX) and penicillin G (PEN G) were injected intramuscularly to pigs, and concentrations of these analytes in the oral fluid were assessed. Ultra-high-performance liquid chromatography coupled with mass spectrometry (UHPLC-MS/MS) was used to quantify the analytes. On the first day of medication, the highest concentrations for SDX and TRMP at the level of 22,300 µg/kg and 14,100 µg/kg were found, respectively. The concentrations of LIN (10,500 µg/kg) and TIAM (7600 µg/kg) were also relatively high. The peak of TYL was recorded on the second day of drug administration. Most of the analytes were present in oral fluid for 30 days, apart from TYL, which was detected for 27 days. It was found that AMX and PEN G were quantified only for 5 and 8 days, respectively, at very low concentrations. It was found that oral fluid can be used for the verification of antibiotics on pig farms.Entities:
Keywords: UHPLC-MS/MS; antibiotics; food safety; oral fluid; pigs
Year: 2022 PMID: 35215336 PMCID: PMC8879095 DOI: 10.3390/ph15020225
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Validation parameters.
| Analyte | Repeatability (CV, %) | Reproducibility (CV, %) | Recovery (%) | LOD (µg/L) | LOQ (µg/L) |
|---|---|---|---|---|---|
| Sulfadoxine | 6.39 ± 1.3 | 12.7 ± 2.6 | 87.6 ± 6.6 | 2 | 5 |
| Trimetophrim | 8.92 ± 1.1 | 11.45 ± 2.4 | 97.3 ± 4.4 | 2 | 5 |
| Lincomycin | 7.07 ± 1.5 | 13.2 ± 2.9 | 94.2 ± 4.2 | 1 | 2 |
| Tiamulin | 4.66 ± 1.1 | 10.1 ± 2.2 | 106 ± 5.6 | 1 | 2 |
| Tylosin | 9.59 ± 1.6 | 14.2 ± 3.1 | 87.9 ± 4.9 | 2 | 5 |
| Amoxycyllin | 9.55 ± 1.8 | 14.9 ± 3.8 | 107 ± 4.6 | 5 | 10 |
| Penicillin G | 9.91 ± 1.9 | 12.0 ± 2.7 | 101 ± 4.1 | 2 | 5 |
Figure 1Chromatograms of oral fluid samples spiked at validation level (VL) with analysed compounds and corresponding internal standards (IS), (a) AMX—amoxicillin, (b) TYL—tylosin, AZT—azithromycin, (c) LIN—lincomycin, (d) SDX—sulfadoxine, SFF—sulfaphenazole, (e) TIAM—tiamulin, (f) TRMP—trimethoprim, (g) PEN G—penicillin G.
Results of oral fluid samples analysis.
| Avarage Concentrations (µg/L) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Period | Time (d) | SDX + TRMP | LIN | TIAM | TYL | AMX | PEN G | |
| Treatment | 1 | 22,300 ± 3555 | 14,100 ± 2556 | 10,500 ± 1889 | 7600 ± 1055 | 396 ± 68 | 11.3 ± 1.6 | 93 ± 21 |
| 2 | 5860 ± 1155 | 2810 ± 556 | 2960 ± 446 | 2520 ± 355 | 958 ± 166 | 15.2 ± 2.3 | 50 ± 15 | |
| 3 | 4570 ± 766 | 1810 ± 311 | 4250 ± 559 | 2460 ± 311 | 832 ± 142 | 14.6 ± 1.8 | 11 ± 4.6 | |
| Posttreatment | 4 | 4010 ± 601 | 1030 ± 221 | 1550 ± 211 | 1560 ± 225 | 654 ± 111 | 11.4 ± 1.4 | 16 ± 5.4 |
| 5 | 5780 ± 788 | 1400 ± 255 | 1674 ± 199 | 1540 ± 233 | 538 ± 96 | 11.2 ± 1.6 | 5.2 ± 1.1 | |
| 6 | 4070 ± 669 | 1280 ± 198 | 1790 ± 203 | 2960 ± 299 | 475 ± 89 | <LOQ | 52 ± 13 | |
| 7 | 310 ± 98 | 264 ± 73 | 1480 ± 186 | 2570 ± 254 | 175 ± 54 | <LOQ | 32 ± 7.2 | |
| 8 | 392 ± 88 | 125 ± 41 | 437 ± 101 * | 875 ± 156 | 118 ± 41 | <LOQ | 6 ± 1.2 | |
| 9 | 386 ± 72 | 128 ± 38 | 457 ± 96 | 567 ± 111 | 158 ± 62 | <LOQ | <LOQ * | |
| 10 | 134 ± 49 | 36.4 ± 15 | 420 ± 83 | 621 ± 124 | 49.3 ± 13 | <LOQ | <LOQ | |
| 11 | 247 ± 62 * | 67.1 ± 20 * | 194 ± 55 | 279 ± 66 | 54.4 ± 16 | <LOQ * | <LOQ | |
| 12 | 74.8 ± 21 | 25.2 ± 9.6 | 257 ± 76 | 254 ± 69 | 140 ± 36 | <LOQ | <LOQ | |
| 13 | 68.0 ± 16 | 22.0 ± 8.7 | 131 ± 41 | 138 ± 43 * | 32.3 ± 11 | <LOQ | <LOQ | |
| 14 | 77.4 ± 18 | 22.1 ± 6.4 | 125 ± 33 | 269 ± 71 | 30.6 ± 8.4 | <LOQ | <LOQ | |
| 15 | 69.8 ± 14 | 31.6 ± 11 | 277 ± 61 | 156 ± 41 | 19.2 ± 5.2 | <LOQ | <LOQ | |
| 16 | 78.4 ± 12 | 24.2 ± 8.2 | 337 ± 69 | 279 ± 68 | 52.8 ± 33 | <LOQ | <LOQ | |
| 17 | 47.0 ± 18 | 18.9 ± 4.8 | 128 ± 28 | 182 ± 49 | 31.9 ± 10 | <LOQ | <LOQ | |
| 18 | 44.2 ± 16 | 13.0 ± 3.6 | 302 ± 51 | 176 ± 52 | 13.9 ± 3.6 | <LOQ | <LOQ | |
| 19 | 58.4 ± 11 | 42.0 ± 14 | 279 ± 44 | 202 ± 45 | 16.1 ± 4.6 | <LOQ | <LOQ | |
| 20 | 76.4 ± 14 | 36.4 ± 10 | 376 ± 52 | 133 ± 36 | 25.4 ± 7.7 | <LOQ | <LOQ | |
| 21 | 21.4 ± 7.3 | 10.2 ± 4.4 | 252 ± 39 | 148 ± 32 | 9.2 ± 2.1 | <LOQ | <LOQ | |
| 22 | 25.3 ± 6.9 | 46.4 ± 16 | 142 ± 24 | 220 ± 44 | 5.5 ± 1.1 | <LOQ | <LOQ | |
| 23 | 15.9 ± 7.2 | 6.9 ± 2.4 | 298 ± 33 | 146 ± 29 | 5.4 ± 0.8 | <LOQ | <LOQ | |
| 24 | 37.0 ± 5.4 | 19.4 ± 5.5 | 326 ± 47 | 310 ± 55 | 6.6 ± 0.9 * | <LOQ | <LOQ | |
| 25 | 31.5 ± 6.3 | 17.8 ± 4.1 | 180 ± 44 | 193 ± 33 | 5.0 ± 1.3 | <LOQ | <LOQ | |
| 26 | 19.1 ± 4.2 | 15.9 ± 3.6 | 160 ± 36 | 66.4 ± 12 | 3.0 ± 0.5 | <LOQ | <LOQ | |
| 27 | 19.3 ± 3.7 | 10.4 ± 2.9 | 205 ± 43 | 54.3 ± 14 | 6.8 ± 1.7 | <LOQ | <LOQ | |
| 28 | 35.0 ± 8.1 | 16.5 ± 6.2 | 103 ± 26 | 35.8 ± 17 | <LOQ | <LOQ | <LOQ | |
| 29 | 30.4 ± 7.6 | 21.2 ± 9.4 | 85.6 ± 16 | 40.6 ± 21 | <LOQ | <LOQ | <LOQ | |
| 30 | 23.0 ± 6.2 | 22.4 ± 9.1 | 58.1 ± 12 | 46.9 ± 19 | <LOQ | <LOQ | <LOQ | |
LOQ—limit of quantification. *—withdrawal period for each compound.
Drugs and dosage administered to animals.
| Administered Drug | Active Substance | Group of Antibacterials | Withdrawal Period for Tissues (Days) | Dosage (Active Substance Per 1 kg of Body Weight) | Practical Dosage |
|---|---|---|---|---|---|
| Borgal 24% | trimethoprim | diaminopyrimidines | 8 | 3 mg of trimethoprim and 12 mg of sulfadoxine | 1 mL for 16 kg, 2× with 48 h interval |
| sulfadoxine | sulfonamides | ||||
| Biotyl 200 | tylosin | macrolide | 21 | 5 mg | 1 mL for 40 kg, 3× with 24 h interval |
| Lincomycin VMD | lincomycin | lincosamides | 5 | 10 mg | 1 mL for 10 kg, 3× with 24 h interval |
| Probencil | penicillin G | penicillins | 6 | 10 mg | 1 mL for 30 kg, 3× with 24 h interval |
| Tiamowet 200 | tiamuline | pleuromutilins | 10 | 6 mg | 1 mL for 20 kg, 3× with 24 h interval |
| Vetrimoxin LA | amoxicillin | penicillins | 8 | 15 mg | 1 mL for 10 kg, 2× with 48 h interval |
MS/MS parameters and summary of the MRM monitored for presented analytes.
| Analyte | Parent Ion ( | Daughter Ion(s) ( | CXP (V) | DP (V) | CE (eV) | Dwell Time (msec) |
|---|---|---|---|---|---|---|
| SDX | 310.9 | 156; 108 | 13 | 60 | 25; 40 | 50 |
| TRMP | 292.1 | 262; 231 | 5 | 52 | 36; 33 | 70 |
| LIN | 407.2 | 126; 359 | 7 | 74 | 36; 28 | 50 |
| TIAM | 494.4 | 192; 119 | 18 | 128 | 30; 56 | 50 |
| TYL | 916 | 174; 772 | 20 | 110 | 52; 42 | 50 |
| AMX | 366.1 | 349; 208 | 8 | 45 | 12; 18 | 100 |
| PEN G | 335.1 | 160; 176 | 12 | 60 | 17; 48 | 100 |
| SFF (IS) | 315.1 | 156 | 15 | 90 | 26 | 50 |
| LIN d3 (IS) | 410.0 | 129 | 13 | 66 | 44 | 50 |
| AMX d4 (IS) | 371.0 | 354 | 13 | 35 | 15 | 50 |
| AZT (IS) | 759.0 | 591 | 13 | 89 | 40 | 50 |